Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study

BACKGROUND/AIMS: Olmesartan, a widely used angiotensin II receptor blocker (ARB), has been linked to sprue-like enteropathy. No cases of olmesartan-associated enteropathy have been reported in Northeast Asia. We investigated the associations between olmesartan and other ARBs and the incidence of ent...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Seng Chan, Park, Hojun, Yoon, Dukyong, Park, Sooyoung, Joung, Boyoung, Park, Rae Woong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325440/
https://www.ncbi.nlm.nih.gov/pubmed/29172402
http://dx.doi.org/10.3904/kjim.2017.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325440/
https://www.ncbi.nlm.nih.gov/pubmed/29172402
http://dx.doi.org/10.3904/kjim.2017.002

Ejemplares similares